Ganciclovir
1 NDC across 1 manufacturer|0 Generic,1 Brand
Ganciclovir is used to treat aids-related opportunistic infections and cytomegalovirus retinitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 22, 1994, and the first generic was approved Jun 27, 2003. In 2024, Medicare Part D spent $9 million on Ganciclovir across 19,000 claims for 11,000 beneficiaries.
Ganciclovir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $91.26 to $91.26 per GM. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$91.26 – $91.26
per GM
7d Activity
avg -0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing GANCICLOVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZIRGAN 0.15% OPHTHALMIC GEL | $91.2570 per GM | -0.03% |
Frequently Asked Questions
What is Ganciclovir used to treat?
Ganciclovir is used to treat aids-related opportunistic infections and cytomegalovirus retinitis, per the National Library of Medicine's MED-RT classification.
When did Ganciclovir become available as a generic?
FDA approved the first generic Ganciclovir (ANDA) on Jun 27, 2003.
How much does Medicare spend on Ganciclovir?
In 2024, Medicare Part D spent $9 million on Ganciclovir across 19,000 claims for 11,000 beneficiaries.
How many Ganciclovir products are on the market?
The Ganciclovir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Ganciclovir?
NADAC reference prices for Ganciclovir range from $91.2570 to $91.2570 per GM.
Which manufacturers make Ganciclovir?
1 manufacturer lists Ganciclovir in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (1).
How has the price of Ganciclovir changed recently?
Over the past 7 days, 0 Ganciclovir NDCs rose and 2 fell, with a market-wide average change of -0.0%.